Sleep, inflammation, and disease

Sleep, Health and Society: From Aetiology to Public Health

Volumn , Issue , 2011, Pages

  Miller, Michelle A ^a   Cappuccio, Francesco P ^a,b  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Inflammation; Innate immunity; Obstructive sleep apnoea; OSA; Sleep; Toll like receptors

Indexed keywords

EID: 84920887398     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780199566594.003.0011     Document Type: Chapter

References (115)

1. Ayas, N.T., White, D.P., Manson, J.E., et al. (2003). A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med, 163(2), 205-209.
2. Bailey, K.L., Wyatt, T.A., Romberger, D.J. & Sisson, J.H. (2009). Alcohol functionally upregulates Tolllike receptor 2 in airway epithelial cells. Alcohol Clin Exp Res, 33(3), 499-504.
3. Balarajan, R. (1995). Ethnicity and variations in the nation's health. Health Trends, 27(4), 114-119.
4. Banks, S. & Dinges, D.F. (2007). Behavioral and physiological consequences of sleep restriction. J Clin Sleep Med, 3(5), 519-528.
5. Bradley, T.D. & Floras, J.S. (2009). Obstructive sleep apnoea and its cardiovascular consequences. Lancet, 373(9657), 82-93.
6. Brook, R.D. & Julius, S. (2000). Autonomic imbalance, hypertension, and cardiovascular risk. Am J Hypertens, 13(6 Pt 2), 112S-122S.
7. Buckley, T.M. & Schatzberg, A.F. (2005). On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab, 90(5), 3106-3114.
8. Burckhardt, I.C., Gozal, D., Dayyat, E., et al. (2008). Green tea catechin polyphenols attenuate behavioral and oxidative responses to intermittent hypoxia. Am J Respir Crit Care Med, 177(10), 1135-1141.
9. Burioka, N., Koyanagi, S., Endo, M., et al. (2008). Clock gene dysfunction in patients with obstructive sleep apnoea syndrome. Eur Respir J, 32(1), 105-112.
10. Capaldi Ii, V.F., Handwerger, K., Richardson, E. & Stroud, L.R. (2005). Associations between sleep and cortisol responses to stress in children and adolescents: a pilot study. Behav Sleep Med, 3(4), 177-192.
11. Cappuccio, F.P., Stranges, S., Kandala, N.B., et al. (2007). Gender-specific associations of short sleep duration with prevalent and incident hypertension: the Whitehall II Study. Hypertension, 50(4), 693-700.
12. Cappuccio, F.P., Taggart, F.M., Kandala, N.B., et al. (2008). Meta-analysis of short sleep duration and obesity in children and adults. Sleep, 31(5), 619-626.
13. Chaput, J.P., Brunet, M. & Tremblay, A. (2006). Relationship between short sleeping hours and childhood overweight/obesity: results from the 'Quebec en Forme' Project. Int J Obes (Lond), 30(7), 1080-1085.
14. Chobanian, A.V., Bakris, G.L., Black, H.R., et al. (2003). Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension, 42(6), 1206-1252.
15. Chogle, A.R. & Chakravarty, A. (2007). Cardiovascular events in systemic lupus erythematosus and rheumatoid arthritis: emerging concepts, early diagnosis and management. J Assoc Physicians India, 55, 32-40.
16. Coughlin, S.R., Mawdsley, L., Mugarza, J.A., Calverley, P.M. & Wilding, J.P. (2004). Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J, 25(9), 735-741.
17. Dorkova, Z., Petrasova, D., Molcanyiova, A., Popovnakova, M. & Tkacova, R. (2008). Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest, 134(4), 686-692.
18. Drager, L.F., Bortolotto, L.A., Figueiredo, A.C., Krieger, E.M. & Lorenzi, G.F. (2007). Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med, 176(7), 706-712.
19. Edell-Gustafsson, U., Svanborg, E. & Swahn, E. (2006). A gender perspective on sleeplessness behavior, effects of sleep loss, and coping resources in patients with stable coronary artery disease. Heart Lung, 35(2), 75-89.
20. Ferrie, J.E., Shipley, M.J., Cappuccio, F.P., et al. (2007). A prospective study of change in sleep duration: associations with mortality in the Whitehall II cohort. Sleep, 30(12), 1659-1666.
21. Frey, D.J., Fleshner, M. & Wright, K.P., Jr. (2007). The effects of 40 hours of total sleep deprivation on inflammatory markers in healthy young adults. Brain Behav Immun, 21(8), 1050-1057.
22. Gangwisch, J.E., Heymsfield, S.B., Boden-Albala, B., et al. (2006). Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension, 47(5), 833-839.
23. Gozal, D. & Kheirandish-Gozal, L. (2008). Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more. Am J Respir Crit Care Med, 177(4), 369-375.
24. Gozal, D., Serpero, L.D., Sans, C.O. & Kheirandish-Gozal, L. (2008). Systemic inflammation in nonobese children with obstructive sleep apnea. Sleep Med, 9(3), 254-259.
25. Greenberg, H., Ye, X., Wilson, D., Htoo, A.K., Hendersen, T. & Liu, S.F. (2006). Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo. Biochem Biophys Res Commun, 343(2), 591-596.
26. Guilleminault, C., Kirisoglu, C. & Ohayon, M.M. (2004). C-reactive protein and sleep-disordered breathing. Sleep, 27(8), 1507-1511.
27. Gundersen, Y., Opstad, P.K., Reistad, T., Thrane, I. & Vaagenes, P. (2006). Seven days' around the clock exhaustive physical exertion combined with energy depletion and sleep deprivation primes circulating leukocytes. Eur J Appl Physiol, 97(2), 151-157.
28. Haack, M., Pollmacher, T. & Mullington, J.M. (2004). Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in healthy volunteers. Brain Behav Immun, 18(4), 361-367.
29. Hak, A.E., Pols, H.A., Stehouwer, C.D., et al. (2001). Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study. J Clin Endocrinol Metab, 86(9), 4398-4405.
30. Harsch, I.A., Koebnick, C., Wallaschofski, H., et al. (2004). Resistin levels in patients with obstructive sleep apnoea syndrome-the link to subclinical inflammation? Med Sci Monit, 10, CR510-CR515.
31. Horrocks, N. & Pounder, R. (2006). Working the night shift: preparation, survival and recovery-a guide for junior doctors. Clin Med, 6(1), 61-67.
32. Iesato, K., Tatsumi, K., Saibara, T., et al. (2007). Decreased lipoprotein lipase in obstructive sleep apnea syndrome. Circ J, 71(8), 1293-1298.
33. Irwin, M. (2002). Effects of sleep and sleep loss on immunity and cytokines. Brain Behav Immun, 16(5), 503-512.
34. Irwin, M., Rinetti, G., Redwine, L., Motivala, S., Dang, J. & Ehlers, C. (2004). Nocturnal proinflammatory cytokine-associated sleep disturbances in abstinent African American alcoholics. Brain Behav Immun, 18(4), 349-360.
35. Irwin, M.R., Wang, M., Campomayor, C.O., Collado-Hidalgo, A. & Cole, S. (2006). Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med, 166(16), 1756-1762.
36. Irwin, M.R., Wang, M., Ribeiro, D., et al. (2008). Sleep loss activates cellular inflammatory signaling. Biol Psychiatry, 64(6), 538-540.
37. Kasasbeh, E., Chi, D.S. & Krishnaswamy, G. (2006). Inflammatory aspects of sleep apnea and their cardiovascular consequences. South Med J, 99(1), 58-67.
38. Kendall-Tackett, K.A. (2007). Inflammation, cardiovascular disease, and metabolic syndrome as sequelae of violence against women: the role of depression, hostility, and sleep disturbance. Trauma Violence Abuse, 8(2), 117-126.
39. Knutson, K.L. (2005). Sex differences in the association between sleep and body mass index in adolescents. J Pediatr, 147(6), 830-834.
40. Knutson, K.L., Spiegel, K., Penev, P. & Van, C.E. (2007). The metabolic consequences of sleep deprivation. Sleep Med Rev, 11(3), 163-178.
41. Kohler, M., Ayers, L., Pepperell, J.C., et al. (2009). Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial. Thorax, 64(1), 67-73.
42. Kokturk, O., Ciftci, T.U., Mollarecep, E. & Ciftci, B. (2005). Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome. Int Heart J, 46(5), 801-809.
43. Krueger, J.M. (2008). The role of cytokines in sleep regulation. Curr Pharm Des, 14(32), 3408-3416.
44. Krueger, J.M. & Majde, J.A. (1994). Microbial products and cytokines in sleep and fever regulation. Crit Rev Immunol, 14(3-4), 355-379.
45. Krueger, J.M., Obal, F.J., Fang, J., Kubota, T. & Taishi, P. (2001). The role of cytokines in physiological sleep regulation. Ann N Y Acad Sci, 933, 211-221.
46. Lam, J.C. & Ip, M.S. (2007). An update on obstructive sleep apnea and the metabolic syndrome. Curr Opin Pulm Med, 13(6), 484-489.
47. Lange, T., Dimitrov, S., Fehm, H.L., Westermann, J. & Born, J. (2006). Shift of monocyte function toward cellular immunity during sleep. Arch Intern Med, 166(16), 1695-1700.
48. Lange, T., Perras, B., Fehm, H.L. & Born, J. (2003). Sleep enhances the human antibody response to hepatitis A vaccination. Psychosom Med, 65(5), 831-835.
49. Lavie, L. & Lavie, P. (2008). Smoking interacts with sleep apnea to increase cardiovascular risk. Sleep Med, 9(3), 247-253.
50. Legramante, J.M. & Galante, A. (2005). Sleep and hypertension: a challenge for the autonomic regulation of the cardiovascular system. Circulation, 112(6), 786-788.
51. Luthje, L. & Andreas, S. (2008). Obstructive sleep apnea and coronary artery disease. Sleep Med Rev, 12(1), 19-31.
52. Majde, J.A. & Krueger, J.M. (2005). Links between the innate immune system and sleep. J Allergy Clin Immunol, 116(6), 1188-1198.
53. Mallion, J.M., Baguet, J.P., Siche, J.P., Tremel, F. & De, G.R. (1999). Clinical value of ambulatory blood pressure monitoring. J Hypertens, 17(5), 585-595.
54. McNicholas, W.T. (2009). Obstructive sleep apnea and inflammation. Prog.Cardiovasc Dis, 51(5), 392-399.
55. Meier-Ewert, H.K., Ridker, P.M., Rifai, N., et al. (2004). Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol, 43(4), 678-683.
56. Meisinger, C., Heier, M. & Loewel, H. (2005). Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population. Diabetologia, 48(2), 235-241.
57. Miller, M.A. & Cappuccio, F.P. (2006). Cellular adhesion molecules and their relationship with measures of obesity and metabolic syndrome in a multiethnic population. Int J Obes (Lond), 30(8), 1176-1182.
58. Miller, M.A. & Cappuccio, F.P. (2007). Inflammation, sleep, obesity and cardiovascular disease. Curr Vasc Pharmacol, 5(2), 93-102.
59. Miller, M.A., Kandala, N.B., Kivimaki, M., et al. (2009a). Gender differences in the cross-sectional relationships between sleep duration and markers of inflammation: Whitehall II study. Sleep, 32(7), 857-864.
60. Miller, M.A., McTernan, P.G., Harte, A.L., et al. (2009b). Ethnic and sex differences in circulating endotoxin levels: a novel marker of atherosclerotic and cardiovascular risk in a British multi-ethnic population. Atherosclerosis, 203(2), 494-502.
61. Miller, M.A., Sagnella, G.A., Kerry, S.M., Strazzullo, P., Cook, D.G. & Cappuccio, F.P. (2003). Ethnic differences in circulating soluble adhesion molecules: the Wandsworth Heart and Stroke Study. Clin Sci (Lond), 104(6), 591-598.
62. Motivala, S.J., Sarfatti, A., Olmos, L. & Irwin, M.R. (2005). Inflammatory markers and sleep disturbance in major depression. Psychosom Med, 67(2), 187-194.
63. Mullington, J.M., Hinze-Selch, D. & Pollmacher, T. (2001). Mediators of inflammation and their interaction with sleep: relevance for chronic fatigue syndrome and related conditions. Ann N Y Acad Sci, 933, 201-210.
64. Murck, H., Uhr, M., Ziegenbein, M., et al. (2006). Renin-angiotensin-aldosterone system, HPA-axis and sleep-EEG changes in unmedicated patients with depression after total sleep deprivation. Pharmacopsychiatry, 39(1), 23-29.
65. Narkiewicz, K., Wolf, J., Lopez-Jimenez, F. & Somers, V.K. (2005). Obstructive sleep apnea and hypertension. Curr Cardiol Rep, 7(6), 435-440.
66. National Sleep Foundation (2005). Sleep in America Poll: Summary of Findings. Washington, DC: National Sleep Foundation. Available at: , accessed on 30.04.10.
67. Ohga, E., Tomita, T., Wada, H., Yamamoto, H., Nagase, T. & Ouchi, Y. (2003). Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol, 94(1), 179-184.
68. Okun, M.L., Coussons-Read, M. & Hall, M. (2009). Disturbed sleep is associated with increased Creactive protein in young women. Brain Behav Immun, 23(3), 351-354.
69. Patel, S.R. & Hu, F.B. (2008). Short sleep duration and weight gain: a systematic review. Obesity (Silver Spring), 16(3), 643-653.
70. Patel, S.R., Zhu, X., Storfer-Isser, A., et al. (2009). Sleep duration and biomarkers of inflammation. Sleep, 32(2), 200-204.
71. Peled, N., Kassirer, M., Kramer, M.R., et al. (2008). Increased erythrocyte adhesiveness and aggregation in obstructive sleep apnea syndrome. Thromb Res, 121(5), 631-636.
72. Peled, N., Kassirer, M., Shitrit, D., et al. (2007). The association of OSA with insulin resistance, inflammation and metabolic syndrome. Respir Med, 101(8), 1696-1701.
73. Pepperell, J.C., Ramdassingh-Dow, S., Crosthwaite, N., et al. (2002). Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet, 359(9302), 204-210.
74. Phillips, B.G., Kato, M., Narkiewicz, K., Choe, I. & Somers, V.K. (2000). Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol, 279(1), H234-H237.
75. Phillips, C.L., Yang, Q., Williams, A., et al. (2007). The effect of short-term withdrawal from continuous positive airway pressure therapy on sympathetic activity and markers of vascular inflammation in subjects with obstructive sleep apnoea. J Sleep Res, 16(2), 217-225.
76. Pickering, T.G. & Kario, K. (2001). Nocturnal non-dipping: what does it augur? Curr Opin Nephrol Hypertens, 10(5), 611-616.
77. Poirier, P., Giles, T.D., Bray, G.A., et al. (2006). Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation, 113(6), 898-918.
78. Prinz, P.N. (2004). Age impairments in sleep, metabolic and immune functions. Exp Gerontol, 39(11-12), 1739-1743.
79. Punjabi, N.M., Beamer, B.A., Jain, A., Spencer, M.E. & Fedarko, N. (2007). Elevated levels of neopterin in sleep-disordered breathing. Chest, 132(4), 1124-1130.
80. Ranjbaran, Z., Keefer, L., Stepanski, E., Farhadi, A. & Keshavarzian, A. (2007). The relevance of sleep abnormalities to chronic inflammatory conditions. Inflamm Res, 56(2), 51-57.
81. Resnick, H.E., Redline, S., Shahar, E., et al. (2003). Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care, 26(3), 702-709.
82. Resta, O., Bonfitto, P., Sabato, R., De, P.G. & Barbaro, M.P. (2004). Prevalence of obstructive sleep apnoea in a sample of obese women: effect of menopause. Diabetes Nutr Metab, 17(5), 296-303.
83. Rosenfeld, Y. & Shai, Y. (2006). Lipopolysaccharide (Endotoxin)-host defense antibacterial peptides interactions: role in bacterial resistance and prevention of sepsis. Biochim Biophys Acta, 1758(9), 1513-1522.
84. Roubenoff, R., Parise, H., Payette, H.A., et al. (2003). Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. Am J Med, 115(6), 429-435.
85. Ryan, S., Nolan, G.M., Hannigan, E., Cunningham, S., Taylor, C. & McNicholas, W.T. (2007). Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax, 62(6), 509-514.
86. Ryan, S., Taylor, C.T. & McNicholas, W.T. (2005). Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation, 112(17), 2660-2667.
87. Santos, R.V., Tufik, S. & de Mello, M.T. (2007). Exercise, sleep and cytokines: is there a relation? Sleep Med Rev, 11(3), 231-239.
88. Scharf, S.M., Seiden, L., DeMore, J. & Carter-Pokras, O. (2004). Racial differences in clinical presentation of patients with sleep-disordered breathing. Sleep Breath, 8(4), 173-183.
89. Siegel, J.M. (2005). Clues to the functions of mammalian sleep. Nature, 437(7063), 1264-1271.
90. Spiegel, K., Knutson, K., Leproult, R., Tasali, E. & Van, C.E. (2005a). Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol, 99(5), 2008-2019.
91. Spiegel, K., Leproult, R., Van Cauter, E. (2005b). Metabolic and endocrine changes. In: Kushida, C. (ed.), Sleep Deprivation: Basic Science, Physiology, and Behaviour, vol. 192. New York, NY: Marcel Dekker, pp. 293-318.
92. Spiegel, K., Tasali, E., Penev, P. & Van, C.E. (2004). Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med, 141(11), 846-850.
93. Steiropoulos, P., Kotsianidis, I., Nena, E., et al. (2009). Long-term effect of continuous positive airway pressure therapy on inflammation markers of patients with obstructive sleep apnea syndrome. Sleep, 32(4), 537-543.
94. Steiropoulos, P., Tsara, V., Nena, E., et al. (2007). Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome. Chest, 132(3), 843-851.
95. Stranges, S., Cappuccio, F.P., Kandala, N.B., et al. (2008a). Cross-sectional versus prospective associations of sleep duration with changes in relative weight and body fat distribution: the Whitehall II Study. Am J Epidemiol, 167(3), 321-329.
96. Stranges S, Dorn JM, Cappuccio FP, et al. (2009). A population-based study of reduced sleep duration and hypertension: the strongest association may be in premenopausal women. J Hypertens [Epub ahead of print].
97. Stranges, S., Dorn, J.M., Shipley, M.J., et al. (2008b). Correlates of short and long sleep duration: a cross-cultural comparison between the United Kingdom and the United States: the Whitehall II Study and the Western New York Health Study. Am J Epidemiol, 168(12), 1353-1364.
98. Strike, P.C. & Steptoe, A. (2003). New insights into the mechanisms of temporal variation in the incidence of acute coronary syndromes. Clin Cardiol, 26(11), 495-499.
99. Suarez, E.C. (2008). Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity. Brain Behav Immun, 22(6), 960-968.
100. Taheri, S., Austin, D., Lin, L., Nieto, F.J., Young, T. & Mignot, E. (2007). Correlates of serum Creactive protein (CRP)-no association with sleep duration or sleep disordered breathing. Sleep, 30(8), 991-996.
101. Tauman, R., Ivanenko, A., O'Brien, L.M. & Gozal, D. (2004). Plasma C-reactive protein levels among children with sleep-disordered breathing. Pediatrics, 113(6), e564-e569.
102. Teramoto, S., Yamamoto, H. & Ouchi, Y. (2003). Increased C-reactive protein and increased plasma interleukin-6 may synergistically affect the progression of coronary atherosclerosis in obstructive sleep apnea syndrome. Circulation, 107(5), E40.
103. Trayhurn, P., Bing, C. & Wood, I.S. (2006). Adipose tissue and adipokines-energy regulation from the human perspective. J Nutr, 136(7), 1935S-1939S.
104. van Leuven, S.I., Kastelein, J.J., Hayden, M.R., d'Cruz, D., Hughes, G.R. & Stroes, E.S. (2005). Cardiovascular disease in systemic lupus erythematosus: has the time for action come? Curr Opin Lipidol, 16(5), 501-506.
105. Van Cauter, E. & Spiegel, K. (1999). Sleep as a mediator of the relationship between socioeconomic status and health: a hypothesis. Ann N Y Acad Sci, 896, 254-261.
106. Vega, G.L. (2004). Obesity and the metabolic syndrome. Minerva Endocrinol, 29(2), 47-54.
107. Vgontzas, A.N. (2008). Does obesity play a major role in the pathogenesis of sleep apnoea and its associated manifestations via inflammation, visceral adiposity, and insulin resistance? Arch Physiol Biochem, 114(4), 211-223.
108. Vgontzas, A.N., Bixler, E.O. & Chrousos, G.P. (2005). Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev, 9(3), 211-224.
109. Vgontzas, A.N., Papanicolaou, D.A., Bixler, E.O., Kales, A., Tyson, K. & Chrousos, G.P. (1997). Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab, 82(5), 1313-1316.
110. Vgontzas, A.N., Zoumakis, E., Bixler, E.O., et al. (2008). Selective effects of CPAP on sleep apnoeaassociated manifestations. Eur J Clin Invest, 38(8), 585-595.
111. Vgontzas, A.N., Zoumakis, E., Bixler, E.O., et al. (2004). Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab, 89(5), 2119-2126.
112. West, S.D., Nicoll, D.J., Wallace, T.M., Matthews, D.R. & Stradling, J.R. (2007). Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax, 62(11), 969-974.
113. Williams, E., Magid, K. & Steptoe, A. (2005). The impact of time of waking and concurrent subjective stress on the cortisol response to awakening. Psychoneuroendocrinology, 30(2), 139-148.
114. Wolf, J., Lewicka, J. & Narkiewicz, K. (2007). Obstructive sleep apnea: an update on mechanisms and cardiovascular consequences. Nutr Metab Cardiovasc Dis, 17(3), 233-240.
115. Yokoe, T., Minoguchi, K., Matsuo, H., et al. (2003). Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation, 107(8), 1129-1134.